MiMedx Group, Inc MDXG
Analyst Ratings
- Consensus
- Buy — 5 Buy · 0 Hold · 0 Sell (5 analysts)
- Avg. Price Target
- $8.40 (+114.8% upside)
Key Stats
- Today's Range
- $3.85 – $3.93
- 50-Day Range
- $3.67 – $4.99
- 52-Week Range
- $3.02 – $7.97
- Volume
- 1.26 million shs
- Average Volume
- 1.34 million shs
- Market Cap
- $570.60 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 28.72%
- Days to Cover
- 30.03
About MiMedx Group, Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
Related Stocks
Compare head-to-head: MDXG vs SYK·MDXG vs BSX·MDXG vs RMD·MDXG vs GKOS
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.